Overview

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Status:
Completed
Trial end date:
2017-03-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy, safety, and tolerability of dexamethasone sodium phosphate Visulex (DSP-Visulex) after repeated-dose administration in patients with acute anterior uveitis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Aciont Inc
Collaborator:
National Eye Institute (NEI)
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Ophthalmic Solutions
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Tetrahydrozoline